General Information
Revision date
2025-12-01
Product name
Mivacurium chloride, nicotinic acetylcholine antagonist
Substance name
Contains bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl]
CAS No.
106861-44-3
1.2.1 Relevant identified uses
For research use only. Not for use in diagnostic procedures
Manufacturer Name
Abcam Ltd
Emergency telephone
+44 1273 289451
Icons in SDS
Company Information
company name
Abcam Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
technical@abcam.com, sds@abcam.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture GB CLP (SI 2020/1567 as amended) Acute toxicity - Oral Category 3 - (H301)
Contains
bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate dichloride
Signal word
Danger
Hazard statements
H301 - Toxic if swallowed
Precautionary statements
P280 - Wear protective gloves/protective clothing and eye/face protection P264 - Wash face, hands and any exposed skin thoroughly after handling P270 - Do not eat, drink or smoke when using this product P301 + P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor P330 - Rinse mouth P501 - Dispose of contents/ container to an approved waste disposal plant
2.3 Other hazards
Caution - substance not yet tested completely.
2.1 Classification of the substance or mixture
GB CLP (SI 2020/1567 as amended) Acute toxicity - Oral Category 3 - (H301)
